Alachua, Fla.-based AxoGen reported third quarter gross profits of $2.31 million, up 60.4 percent from the same period last year. However, the company's operating loss of $2.28 million was also an increase of 11.5 percent compared to 2012's third quarter. The company's operating expenses increased from $3.48 million in 2012 to $4.58 million in 2013.
More Articles on Devices:
NuVasive Q3 Income at $7k, Up Nearly 250% From Last Year
ArthroCare Profits Increase 4.27% in Q3
Device Companies — 7 Key Notes — Zimmer, Boston Scientific & More
AxoGen Profits Up 60% in Q3 to $2.31M
Spinal TechCopyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.